Alan Colowick - 04 May 2021 Form 4/A - Amendment Insider Report for Harpoon Therapeutics, Inc.

Role
Director
Signature
/s/ Alan Colowick by Christopher Whitmore, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 May 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
14 May 2021, 20:14:08 UTC
Date Of Original Report
07 May 2021
Next filing
18 May 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HARP Director Stock Option (Right to Buy) 0 04 May 2021 Common Stock 10,167 $22.50 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will fully vest and become exercisable on May 4, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date.
F2 Due to administrative error, this option award was erroneously reported on the original Form 4 filed on May 7, 2021. This Form 4/A is being filed solely to correct the original Form 4 filing. Under the terms of the Issuer's Non-Employee Director Compensation Policy, no such option award occurred on the date originally reported.